Exact Mass: 620.3309
Exact Mass Matches: 620.3309
Found 41 metabolites which its exact mass value is equals to given mass value 620.3309,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-{[5,7-dihydroxy-2,2-dimethyl-8-hexanoyl-6-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-acetyl-2,5-cyclohexadien-1-one|yungensin B
2-{[5,7-dihydroxy-2,2-dimethyl-8-hexanoyl-6-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-acetyl-2,5-cyclohexadien-1-one|yungensin B
2-{[5,7-dihydroxy-2-methyl-2-(4-methyl-3-pentenyl)-8-butanoyl-6-chromenyl]-methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-butanoyl-2,5-cyclohexadien-1-one|crassipin A
2-{[5,7-dihydroxy-2-methyl-2-(4-methyl-3-pentenyl)-8-butanoyl-6-chromenyl]-methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-butanoyl-2,5-cyclohexadien-1-one|crassipin A
2-{[5,7-dihydroxy-2,2-dimethyl-6-butanoyl-8-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-butanoyl-2,5-cyclohexadien-1-one|crassipin E
2-{[5,7-dihydroxy-2,2-dimethyl-6-butanoyl-8-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-butanoyl-2,5-cyclohexadien-1-one|crassipin E
Terlakiren
Terlakiren
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
Butobendine
Butobendine
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
[(1S,2R,3R,4S,5R)-5-azaniumyl-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3-azaniumyl-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxycyclohexyl]azanium
[(1S,2R,3R,4S,5R)-5-azaniumyl-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3-azaniumyl-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxycyclohexyl]azanium
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D005765 - Gastrointestinal Agents
(3S)-2-tert-butylsulfinyl-4-[3-(3-cyclopentylprop-1-ynyl)phenyl]-3-(2-hydroxyethyl)-N-[3-(4-morpholinyl)propyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-tert-butylsulfinyl-4-[3-(3-cyclopentylprop-1-ynyl)phenyl]-3-(2-hydroxyethyl)-N-[3-(4-morpholinyl)propyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (9Z,12Z)-octadeca-9,12-dienethioate
S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (9Z,12Z)-octadeca-9,12-dienethioate
4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
2-acetyl-4-(3,7-dimethylocta-2,6-dien-1-yl)-6-[(8-hexanoyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one
2-acetyl-4-(3,7-dimethylocta-2,6-dien-1-yl)-6-[(8-hexanoyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[(3r)-5-oxooxolan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[(3r)-5-oxooxolan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1r,4s,10s,16s,19s)-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
(1r,4s,10s,16s,19s)-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
(4r)-2-acetyl-4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-[(8-hexanoyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one
(4r)-2-acetyl-4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-[(8-hexanoyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one
(1r,4s,10s,16s,19s)-4-[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
(1r,4s,10s,16s,19s)-4-[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[(3s)-5-oxooxolan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[(3s)-5-oxooxolan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1r,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1r,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate
(1r,4s,10s,16s,19s)-4,19-bis[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
(1r,4s,10s,16s,19s)-4,19-bis[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-2,11,14,17,20(23)-pentaen-5-one
